Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE-/- mice by down-regulating PCSK9 via ERK1/2 pathway

Chunyan Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianjun Li(National Research Council Canada)
Annals of Translational Medicine
September 26, 2021
Cited by 33


Related Papers